Year-Round Allergies: Airborne Mold

If your nasal allergy symptoms get worse when the weather turns warmer, outdoor airborne mold could be to blame.

There are many different types of molds, and they can be found both outdoors and indoors. Molds reproduce with microscopic particles called spores, and during warmer seasons, outdoor mold spores are carried in the air like pollen. Mold can also thrive in dark, moist areas such as rotting logs, fallen leaves, and compost piles, and on farms in grain bins and silos.

Mold counts, unfortunately, aren't quite as useful as pollen counts, since some molds prefer dry air and others damp — different types of molds are present in different conditions.

Tips to reduce nasal allergy symptoms
caused by airborne mold

  • Keep windows closed
  • Wear a mask when cutting grass or raking leaves
  • Keep your yard cleared of leaf piles and other damp, dark places where mold can thrive
  • Take off your shoes before coming inside the house
  • To help prevent symptoms, your healthcare professional may tell you to start taking your allergy medicine 1 to 2 weeks before mold season starts in your area
  • Take steps to allergy-proof your home

When Are Airborne Mold Allergies at Their Worst?

Generally, there's more mold in the air as the weather gets warmer. In colder regions, mold increases in the spring and peaks in the summer and fall months. In warmer regions, there may be mold spores in the air all year round.

Small Font
Medium Font
Large Font

email

print

Need to Allergy-Proof Your Home?

every time*

Find out how

Battling Asthma Too?

Give your home an allergy-proofing makeover.

Get started here

* Maximum savings of $50 on up to 12 prescription fills of OMNARIS per year. For qualifying patients. Restrictions apply. Full program rules.

OMNARIS (ciclesonide) Nasal Spray is for the treatment of nasal allergy symptoms associated with seasonal allergic rhinitis (seasonal allergies) in adults and children 6 years of age and older, and with perennial allergic rhinitis (year-round allergies) in adults and adolescents 12 and older.

Important Safety Information

Patients using corticosteroid drugs that weaken the immune system are more susceptible to infection and should avoid exposure to chickenpox or measles. If you have tuberculosis, eye herpes, or untreated infections of any kind, speak to your doctor before using OMNARIS. Yeast infections of the nose and throat may occur.

Patients who have recently had an ulcer in the nose, trauma to the nose or nasal surgery should not use OMNARIS until healing has occurred. Rare instances of nasal irritation and eye problems have been reported following the use of nasal steroids. Talk with your doctor if you have a history of eye problems or experience a change in vision.

Patients taking higher doses of a nasal steroid than recommended, or certain other at-risk individuals, may experience symptoms of a hormonal imbalance, including very rarely changes in menstruation, acne, and weight gain. Like all steroid nasal sprays, OMNARIS may cause slowed growth in children. The growth of children using OMNARIS should be monitored routinely by a healthcare professional.

The most common side effects that may occur with OMNARIS are headache, nosebleed, sore throat and ear pain.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

For more information, please see the OMNARIS Full Prescribing Information and the OMNARIS Patient's Instructions for Use.

OMNARIS is available by prescription. Ask your healthcare professional if OMNARIS is right for you. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

The health information contained on this website is provided for educational purposes only and is not intended to replace discussions with a healthcare professional. This site is intended for U.S. residents only. The product discussed on this site may have different product labeling in different countries. All decisions regarding patient care must be made with a healthcare professional, considering the unique characteristics of the patient.

© 2011 Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Dainippon Sumitomo Pharma Co. Ltd., and is a registered trademark of Dainippon Sumitomo Pharma Co. Ltd.
OMNARIS is a registered trademark of Nycomed GmbH, used with permission.